Link to the University of Pittsburgh Homepage
Link to the University Library System Homepage Link to the Contact Us Form

Utilizing oncolytic vaccinia virus to modulate the tumor microenvironment

DePeaux, Kristin (2024) Utilizing oncolytic vaccinia virus to modulate the tumor microenvironment. Doctoral Dissertation, University of Pittsburgh. (Unpublished)

[img]
Preview
PDF
Download (6MB) | Preview

Abstract

Oncolytic viruses are viruses which lyse tumor cells and stimulate a patient specific anti-tumor and anti-viral immune response. While one oncolytic virus has received FDA approval, clinical success has been limited. To design better oncolytics, we must improve our understanding of their mechanism of action and resistance. In this dissertation, I report that the infection of lymphocytes in the tumor by oncolytic vaccinia virus (VV) is important for the anti-tumor immune response. VV infects suppressive exhausted T cells and leads to their death and inhibiting this death decreases animal survival. I also found that oncolytic vaccinia-resistant tumors have high levels of intratumoral TGFβ. By engineering oncolytic vaccinia to deliver a TGFβR inhibitor, we rendered these tumors sensitive to treatment. Inhibiting TGFβ in the tumor with the immune stimulatory effects of VV reduced the suppression of regulatory T cells, resulting in increased effector T cell function. Overall, we show that oncolytic viruses stimulate an inflammatory immune response in both sensitive and resistant tumor models. In tumors resistant to therapy, it is also necessary to target the suppressive cell types for deletion or reprogramming, to promote a response to VV therapy. While traditionally, oncolytic virus combinations have added more stimulatory therapies, these data suggest the importance of also targeting resistance mechanisms when engineering or combining oncolytics with other therapies.


Share

Citation/Export:
Social Networking:
Share |

Details

Item Type: University of Pittsburgh ETD
Status: Unpublished
Creators/Authors:
CreatorsEmailPitt UsernameORCID
DePeaux, Kristinkrd61@pitt.edukrd610000-0001-8460-727X
ETD Committee:
TitleMemberEmail AddressPitt UsernameORCID
Thesis AdvisorDelgoffe, Greg Mgdelgoffe@pitt.eduGMD34
Committee ChairSarkar, Saumendra Nsaumen@pitt.eduSAUMEN
Committee MemberKane, LPlkane@pitt.eduLKANE
Committee MemberVignali, Dario AAdvignali@pitt.eduDVIGNALI
Committee MemberEmens, Leishaleisha.emens@gmail.com
Date: 16 September 2024
Date Type: Publication
Defense Date: 9 November 2023
Approval Date: 16 September 2024
Submission Date: 16 November 2023
Access Restriction: No restriction; Release the ETD for access worldwide immediately.
Number of Pages: 146
Institution: University of Pittsburgh
Schools and Programs: School of Medicine > Immunology
Degree: PhD - Doctor of Philosophy
Thesis Type: Doctoral Dissertation
Refereed: Yes
Uncontrolled Keywords: immunology, tumor immunology, regulatory t cell, oncolytic virus, oncolytic vaccinia, exhausted t cell
Date Deposited: 16 Sep 2024 18:48
Last Modified: 16 Sep 2024 18:48
URI: http://d-scholarship.pitt.edu/id/eprint/45539

Metrics

Monthly Views for the past 3 years

Plum Analytics


Actions (login required)

View Item View Item